PDS Biotechnology Corporation(NASDAQ:PDSB) 
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cance...
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.01
H 1.02
L 0.91
C 0.95
V 501,647
10EMA 0.95
20EMA 0.95
60EMA 0.95
120EMA 0.95
250EMA 0.95